| Product Code: ETC8263497 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Mauritius saw a diverse mix of top countries exporting oral hypoglycemic agents in 2024, with India, Metropolitan France, Germany, Turkey, and the UK leading the pack. The market experienced a shift from high to moderate concentration, indicating increased competition and potentially more choices for buyers. Despite a slight dip in growth rate from 2023 to 2024, the compound annual growth rate over the past four years has been positive at 4.71%, showcasing steady expansion in the market for oral hypoglycemic agents in Mauritius.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Oral Hypoglycemic Agents (OHAs) Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Oral Hypoglycemic Agents (OHAs) Market - Industry Life Cycle |
3.4 Mauritius Oral Hypoglycemic Agents (OHAs) Market - Porter's Five Forces |
3.5 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By Type of Product, 2021 & 2031F |
3.6 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Mauritius Oral Hypoglycemic Agents (OHAs) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Mauritius |
4.2.2 Growing awareness about the importance of oral hypoglycemic agents in managing diabetes |
4.2.3 Technological advancements in the development of oral hypoglycemic agents |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval of oral hypoglycemic agents |
4.3.2 High cost associated with oral hypoglycemic agents |
4.3.3 Limited access to healthcare services in remote areas of Mauritius |
5 Mauritius Oral Hypoglycemic Agents (OHAs) Market Trends |
6 Mauritius Oral Hypoglycemic Agents (OHAs) Market, By Types |
6.1 Mauritius Oral Hypoglycemic Agents (OHAs) Market, By Type of Product |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Type of Product, 2021- 2031F |
6.1.3 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Sulfonylureas, 2021- 2031F |
6.1.4 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Metformin, 2021- 2031F |
6.1.5 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Thiazolidinediones, 2021- 2031F |
6.1.6 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Alpha-Glucosidase Inhibitors, 2021- 2031F |
6.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.2.3 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Mauritius Oral Hypoglycemic Agents (OHAs) Market Import-Export Trade Statistics |
7.1 Mauritius Oral Hypoglycemic Agents (OHAs) Market Export to Major Countries |
7.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market Imports from Major Countries |
8 Mauritius Oral Hypoglycemic Agents (OHAs) Market Key Performance Indicators |
8.1 Number of diabetes cases diagnosed annually in Mauritius |
8.2 Adoption rate of oral hypoglycemic agents among diabetes patients |
8.3 Rate of adherence to oral hypoglycemic agent treatment plans |
9 Mauritius Oral Hypoglycemic Agents (OHAs) Market - Opportunity Assessment |
9.1 Mauritius Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By Type of Product, 2021 & 2031F |
9.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Mauritius Oral Hypoglycemic Agents (OHAs) Market - Competitive Landscape |
10.1 Mauritius Oral Hypoglycemic Agents (OHAs) Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Oral Hypoglycemic Agents (OHAs) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here